Khosla Ventures
Listed as “Ultima Genomics”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Company website description: Ultima Genomics builds high-throughput sequencing platforms — the UG 100 and UG200 Series — for population-scale genomics at industry-leading cost per genome.
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Listed as “Ultima Genomics”
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.